Dowling-Meara Epidermolysis Bullosa SimplexSymptoms, Doctors, Treatments, Advances & More
Dowling-Meara Epidermolysis Bullosa Simplex Overview
Learn About Dowling-Meara Epidermolysis Bullosa Simplex
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Dermatologists Of Southwest Ohio, Inc.
Anne Lucky is a Dermatologist practicing medicine in Cincinnati, Ohio. Dr. Lucky is rated as an Elite provider by MediFind in the treatment of Dowling-Meara Epidermolysis Bullosa Simplex. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Dystrophic Epidermolysis Bullosa, Epidermolysis Bullosa, Dowling-Meara Epidermolysis Bullosa Simplex, and Dominant Dystrophic Epidermolysis Bullosa. Dr. Lucky is board certified in American Board Of Dermatology and American Board Of Pediatrics. Dr. Lucky is currently accepting new patients.
Lucille Packard Children's Hospital 030962
Joyce Teng is a Pediatrics provider practicing medicine in Palo Alto, California. Dr. Teng is rated as an Elite provider by MediFind in the treatment of Dowling-Meara Epidermolysis Bullosa Simplex. She is also highly rated in 136 other conditions, according to our data. Her clinical expertise encompasses Dowling-Meara Epidermolysis Bullosa Simplex, Dominant Dystrophic Epidermolysis Bullosa, Nevoid Basal Cell Carcinoma Syndrome, Fetal Retinoid Syndrome, and Liver Embolization.
Catherine Laprise practices practicing medicine in Saguenay, Canada. Ms. Laprise is rated as an Elite expert by MediFind in the treatment of Dowling-Meara Epidermolysis Bullosa Simplex. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Dowling-Meara Epidermolysis Bullosa Simplex, Dominant Dystrophic Epidermolysis Bullosa, Asthma, and Epidermolysis Bullosa.
Summary: This Phase II clinical study will assess the efficacy, safety and tolerability of topical TolaSure Gel in adults and pediatric patients (4 years of age and older) diagnosed with generalized intermediate to severe epidermolysis bullosa simplex (EBS). Each patient (40 to complete) will be enrolled in the study and will be randomized to receive either TolaSure Gel or a topical Placebo for daily appli...
Summary: The goal of this clinical trial is to learn about deucravacitinib treatment in adults with inflammatory epidermal genodermatoses . The main question it aims to answer are: describe efficacity and safety of this treatment. Participants will take treatments and have to use bullets during the study period.